Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2025-12-24 @ 12:01 PM
NCT ID:
NCT00824161
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed colorectal adenocarcinoma
* Received prior therapy, at least two regimens, containing a fluoropyrimidine, oxaliplatin, and irinotecan
* Have at least one measurable tumor, as defined by RECIST
* Must be capable of maintaining a central venous line access
Exclusion Criteria:
* Had previous anti-tumor therapy in the 3 weeks prior to study entry
* Have not recovered from all toxicities (excluding alopecia) from prior therapy to baseline or ≤grade 1 prior to study entry
* Have another malignancy in the past 3 years except curatively treated non-melanoma skin cancer or carcinoma in situ of the cervix
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00824161
Study Brief:
Protocol Section:
NCT00824161